EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹5.55 Cr | ₹5.00 Cr | ₹4.91 Cr | ₹5.24 Cr | ₹5.55 Cr |
What is the latest Contingent Liabilities ratio of EVEREST ORGANICS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹5.55 Cr |
| Mar2024 | ₹5.00 Cr |
| Mar2023 | ₹4.91 Cr |
| Mar2022 | ₹5.24 Cr |
| Mar2021 | ₹5.55 Cr |
How is Contingent Liabilities of EVEREST ORGANICS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.55 Cr | 10.90 | |
| Mar2024 | ₹5.00 Cr | 1.83 | |
| Mar2023 | ₹4.91 Cr | -6.35 | |
| Mar2022 | ₹5.24 Cr | -5.50 | |
| Mar2021 | ₹5.55 Cr | - | |
Compare Contingent Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹244.8 Cr | -5.7% | 5.3% | -42.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,893.0 Cr | -0.2% | 7.5% | 5.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,367.0 Cr | -0.9% | 11.5% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,241.0 Cr | 0.5% | 7% | 37.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,010.0 Cr | -3.1% | 4.8% | 10.3% | Stock Analytics | |
| CIPLA | ₹104,366.0 Cr | -5.4% | 5.5% | -13.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.7% |
5.3% |
-42.1% |
| SENSEX | -3.2% |
-3.9% |
-7.5% |
You may also like the below Video Courses